Deal Watch: AbbVie Pays Highest Price Yet Seen For Priority Review Voucher
Executive Summary
Depomed deems increased buyout offer from Horizon as insufficient, possibly leaving Horizon to consider alternative acquisitions. Valeant will pay $1bn to acquire Sprout and its just approved female sexual desire disorder drug Addyi.